Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ ATP13A2 Antibody Blocking Peptide
Shop All Novus Biologicals Products

Click to view available options
Quantity:
0.05 mg
Description
A peptide to ATP13A2. The ATP13A2 Blocking Peptide has been validated for the following applications: Antibody Competition.
Specifications
Specifications
Gene ID (Entrez) | 23400 |
Species | Human |
Content And Storage | Store at -80 C. Avoid freeze-thaw cycles. |
Formulation | Peptide dissolved in dH2O. Contains no BSA. |
For Use With (Application) | This Peptide is Useful as a Blocking Peptide for NB110-41486. IHC and WB Were Reported in Scientific Literature. For Further Blocking Peptide Related Protocol, Click Here . |
Gene Alias | ATPase type 13A2, EC 3.6.3, EC 3.6.3.-, EC 3.6.3.5, EC 3.6.3.8, FLJ26510, HSA9947, KRPPD, PARK9putative ATPase, Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome), probable cation-transporting ATPase 13A2 |
Gene Symbol | ATP13A2 |
Product Type | ATP13A2 |
Quantity | 0.05 mg |
Regulatory Status | RUO - research use only |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction